Annual report pursuant to Section 13 and 15(d)

ACCRUED EXPENSES

v3.22.4
ACCRUED EXPENSES
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
ACCRUED EXPENSES
10.
ACCRUED EXPENSES

 

Accrued expenses consisted of the following:

 

 

 

December 31,
2022

 

 

December 31,
2021

 

 

 

 

 

 

 

 

Accrued pre-clinical and clinical costs

 

$

2,137,317

 

 

$

5,435,464

 

Accrued product development costs

 

 

247,500

 

 

 

203,676

 

Accrued compensation

 

 

2,224,951

 

 

 

2,715,368

 

Accrued administrative costs

 

 

473,376

 

 

 

1,213,699

 

Accrued interest

 

 

916,108

 

 

 

525,105

 

Total

 

$

5,999,252

 

 

$

10,093,312